Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
266 Leser
Artikel bewerten:
(0)

Global Biopreservation Market 2017-2021: Key Vendors are BioLife Solutions, Merck Millipore, Thermo Fisher Scientific & VWR

DUBLIN, July 26, 2017 /PRNewswire/ --

The "Global Biopreservation Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global bio preservation market to grow at a CAGR of 12.43% during the period 2017-2021.

The report, Global Bio Preservation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is growing demand for personalized medicine. The high unmet medical need in the market has driven the demand for personalized medicine, which could offer game-changing opportunities for the vendors. Personalized medicines can offer treatments based on the individual characteristics, needs and preferences.

According to the report, one driver in the market is increasing expenditure on R&D. The global expenditure on R&D is showing consistent growth from last few years. It went up from $522 billion in 1996 to $1.6 trillion in 2014. In 2016, it was approximately $1.9 trillion. The economies of developing countries are growing faster than that of developed countries, which will result in more research facilities and development of institutes over the next five years. The increase in number of research and testing facilities in the field of biopharmaceutical will result in increase in demand for laboratory equipment such biopreservation systems.

Further, the report states that one challenge in the market is improper Infrastructure. Biological samples like blood, lipid, stem cells and others are sensitive to temperature thereby need a proper environment with stable temperature ideally for storage. In many under-developed and developing countries inadequate financial and infrastructure resources restrain the adoption of purpose-designed biopreserving equipment. Lack of funding as well as healthcare cuts have reduced the opportunity to invest in proper infrastructure that can accommodate biopreservation equipment.

Key vendors

  • BioLife Solutions
  • Merck Millipore
  • Thermo Fisher Scientific
  • VWR

Other prominent vendors

  • BioCision
  • Cesca Therapeutics
  • Biomatrica
  • Brooks Automation
  • Core Dynamics
  • Custom Biogenic Systems
  • Lifeline Scientific
  • Helmer Scientific
  • So-Low Environmental Equipment
  • Princeton CryoTech

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market segmentation by application

PART 06: Market segmentation by end-user

PART 07: Geographical segmentation

PART 08: Decision framework

PART 09: Drivers and challenges

PART 10: Market trends

PART 11: Vendor landscape

PART 12: Key vendor analysis

PART 13: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/5tks97/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.